JP2023543803A5 - - Google Patents

Info

Publication number
JP2023543803A5
JP2023543803A5 JP2023519084A JP2023519084A JP2023543803A5 JP 2023543803 A5 JP2023543803 A5 JP 2023543803A5 JP 2023519084 A JP2023519084 A JP 2023519084A JP 2023519084 A JP2023519084 A JP 2023519084A JP 2023543803 A5 JP2023543803 A5 JP 2023543803A5
Authority
JP
Japan
Prior art keywords
nucleotides
pegrna
nucleic acid
rna
linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023519084A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023543803A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/052097 external-priority patent/WO2022067130A2/en
Publication of JP2023543803A publication Critical patent/JP2023543803A/ja
Publication of JP2023543803A5 publication Critical patent/JP2023543803A5/ja
Pending legal-status Critical Current

Links

JP2023519084A 2020-09-24 2021-09-24 プライム編集ガイドｒｎａ、その組成物、及びその使用方法 Pending JP2023543803A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202063083067P 2020-09-24 2020-09-24
US63/083,067 2020-09-24
US202063091272P 2020-10-13 2020-10-13
US63/091,272 2020-10-13
US202163182633P 2021-04-30 2021-04-30
US63/182,633 2021-04-30
US202163231231P 2021-08-09 2021-08-09
US63/231,231 2021-08-09
PCT/US2021/052097 WO2022067130A2 (en) 2020-09-24 2021-09-24 Prime editing guide rnas, compositions thereof, and methods of using the same

Publications (2)

Publication Number Publication Date
JP2023543803A JP2023543803A (ja) 2023-10-18
JP2023543803A5 true JP2023543803A5 (https=) 2024-10-02

Family

ID=78302966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023519084A Pending JP2023543803A (ja) 2020-09-24 2021-09-24 プライム編集ガイドｒｎａ、その組成物、及びその使用方法

Country Status (6)

Country Link
US (1) US20230357766A1 (https=)
EP (1) EP4217490A2 (https=)
JP (1) JP2023543803A (https=)
AU (1) AU2021350835A1 (https=)
CA (1) CA3193099A1 (https=)
WO (1) WO2022067130A2 (https=)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
IL310721B2 (en) 2015-10-23 2025-11-01 Harvard College Nucleobase editors and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
US12390514B2 (en) 2017-03-09 2025-08-19 President And Fellows Of Harvard College Cancer vaccine
US11542496B2 (en) 2017-03-10 2023-01-03 President And Fellows Of Harvard College Cytosine to guanine base editor
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
US12522807B2 (en) 2018-07-09 2026-01-13 The Broad Institute, Inc. RNA programmable epigenetic RNA modifiers and uses thereof
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
WO2020191233A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
WO2020252455A1 (en) 2019-06-13 2020-12-17 The General Hospital Corporation Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
IL297761A (en) 2020-05-08 2022-12-01 Broad Inst Inc Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
CA3189601A1 (en) 2020-07-24 2022-01-27 The General Hospital Corporation Enhanced virus-like particles and methods of use thereof for delivery to cells
EP4232583A1 (en) 2020-10-21 2023-08-30 Massachusetts Institute of Technology Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
US20220145334A1 (en) * 2020-11-06 2022-05-12 Pairwise Plants Services, Inc. Compositions and methods for rna-encoded dna-replacement of alleles
JP2024521811A (ja) 2021-05-28 2024-06-04 サナ バイオテクノロジー，インコーポレイテッド 短縮型ヒヒ内在性レトロウイルス（ＢａＥＶ）エンベロープ糖タンパク質を含む脂質粒子、ならびに関連する方法及び使用
EP4352215A1 (en) * 2021-06-11 2024-04-17 LifeEDIT Therapeutics, Inc. Rna polymerase iii promoters and methods of use
US20240358761A1 (en) 2021-08-11 2024-10-31 Sana Biotechnology, Inc. Genetically modified cells for allogeneic cell therapy
JP2024535677A (ja) 2021-08-11 2024-10-02 サナ バイオテクノロジー，インコーポレイテッド 即時血液媒介性炎症反応を減少させるための同種細胞療法を目的とした遺伝子改変細胞
EP4384598A1 (en) 2021-08-11 2024-06-19 Sana Biotechnology, Inc. Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions
AU2022325232A1 (en) 2021-08-11 2024-02-08 Sana Biotechnology, Inc. Genetically modified primary cells for allogeneic cell therapy
US20250313861A1 (en) 2021-10-22 2025-10-09 Sana Biotechnology, Inc. Methods of engineering allogeneic t cells with a transgene in a tcr locus and associated compositions and methods
WO2023115041A1 (en) 2021-12-17 2023-06-22 Sana Biotechnology, Inc. Modified paramyxoviridae attachment glycoproteins
US20250059239A1 (en) 2021-12-17 2025-02-20 Sana Biotechnology, Inc. Modified paramyxoviridae fusion glycoproteins
EP4463135A2 (en) 2022-01-10 2024-11-20 Sana Biotechnology, Inc. Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses
EP4472646A1 (en) 2022-02-01 2024-12-11 Sana Biotechnology, Inc. Cd3-targeted lentiviral vectors and uses thereof
WO2023150647A1 (en) 2022-02-02 2023-08-10 Sana Biotechnology, Inc. Methods of repeat dosing and administration of lipid particles or viral vectors and related systems and uses
EP4479416A1 (en) 2022-02-17 2024-12-25 Sana Biotechnology, Inc. Engineered cd47 proteins and uses thereof
EP4504921A4 (en) * 2022-04-01 2026-04-15 Prime Medicine Inc METHODS AND COMPOSITIONS FOR EDITING NUCLEOTID SEQUENCES
EP4511488A2 (en) * 2022-04-20 2025-02-26 Tacit Therapeutics, Inc. Stabilization of therapeutic trans-splicing rna molecules in human cells
WO2023215831A1 (en) * 2022-05-04 2023-11-09 Tome Biosciences, Inc. Guide rna compositions for programmable gene insertion
US20250283112A1 (en) * 2022-05-13 2025-09-11 The Regents Of The University Of California Compositions and Methods for RNA Editing
EP4534675A1 (en) * 2022-05-25 2025-04-09 Institute Of Genetics And Developmental Biology, Chinese Academy Of Sciences Method for site-specific insertion of exogenous sequence in genome
US20250354177A1 (en) * 2022-05-30 2025-11-20 Wuhan University System and methods for duplicating target fragments
CN114958767B (zh) * 2022-06-02 2022-12-27 健颐生物科技发展(山东)有限公司 基于hiPSC细胞构建的神经干细胞制剂的制备方法
EP4532702A1 (en) * 2022-06-02 2025-04-09 University of Massachusetts High fidelity nucleotide polymerase chimeric prime editor systems
CN115948461A (zh) * 2022-07-14 2023-04-11 五邑大学 一种双向导碱基基因编辑系统及其应用
WO2024026344A1 (en) * 2022-07-27 2024-02-01 Inscripta, Inc. Modulating cellular repair mechanisms for genomic editing
CN116064517A (zh) * 2022-07-29 2023-05-05 之江实验室 一种先导编辑gRNA的产生方式及其用途
US20260055146A1 (en) 2022-08-24 2026-02-26 Sana Biotechnology, Inc. Delivery of heterologous proteins
CN115948449B (zh) * 2022-09-20 2026-03-27 浙江大学杭州国际科创中心 一种适用于酵母先导编辑的双质粒系统及应用
EP4590819A2 (en) * 2022-09-20 2025-07-30 The Board of Trustees of the Leland Stanford Junior University Methods and compositions to control gene using genome editing
WO2024064838A1 (en) 2022-09-21 2024-03-28 Sana Biotechnology, Inc. Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof
WO2024077267A1 (en) 2022-10-07 2024-04-11 The Broad Institute, Inc. Prime editing methods and compositions for treating triplet repeat disorders
WO2024081820A1 (en) 2022-10-13 2024-04-18 Sana Biotechnology, Inc. Viral particles targeting hematopoietic stem cells
WO2024086586A2 (en) * 2022-10-18 2024-04-25 Flagship Pioneering Innovations Vi, Llc Improved gene editing systems utilizing trans recruiting components
WO2024097313A1 (en) 2022-11-02 2024-05-10 Sana Biotechnology, Inc. Methods for producing t cell therapy products
WO2024119157A1 (en) 2022-12-02 2024-06-06 Sana Biotechnology, Inc. Lipid particles with cofusogens and methods of producing and using the same
WO2024151541A1 (en) 2023-01-09 2024-07-18 Sana Biotechnology, Inc. Type-1 diabetes autoimmune mouse
WO2024168116A1 (en) 2023-02-08 2024-08-15 Prime Medicine, Inc. Genome editing compositions and methods for treatment of myotonic dystrophy
WO2024168147A2 (en) 2023-02-09 2024-08-15 The Broad Institute, Inc. Evolved recombinases for editing a genome in combination with prime editing
WO2024170866A1 (en) * 2023-02-16 2024-08-22 Genome Research Limited Methods for modifying a cell genome
WO2024206125A1 (en) * 2023-03-24 2024-10-03 The Broad Institute, Inc. Use of prime editing for treating sickle cell disease
WO2024215712A2 (en) * 2023-04-11 2024-10-17 University Of Washington Methods for identifying epigenetic factors influencing gene editing and modulating gene editing outcome via epigenetic modulation
WO2024220135A1 (en) 2023-04-17 2024-10-24 University Of Massachusetts Prime editing systems having pegrna with reduced auto-inhibitory interaction
EP4698666A1 (en) 2023-04-18 2026-02-25 Sana Biotechnology, Inc. Universal protein g fusogens and adapter systems thereof and related lipid particles and uses
WO2024220560A1 (en) 2023-04-18 2024-10-24 Sana Biotechnology, Inc. Engineered protein g fusogens and related lipid particles and methods thereof
WO2024220598A2 (en) 2023-04-18 2024-10-24 Sana Biotechnology, Inc. Lentiviral vectors with two or more genomes
AU2024264889A1 (en) 2023-05-03 2025-11-13 Sana Biotechnology, Inc. Methods of dosing and administration of engineered islet cells
EP4716541A2 (en) 2023-05-22 2026-04-01 Sana Biotechnology, Inc. Methods of delivery of islet cells and related methods
WO2024243415A1 (en) 2023-05-23 2024-11-28 The Broad Institute, Inc. Evolved and engineered prime editors with improved editing efficiency
EP4716750A1 (en) 2023-05-23 2026-04-01 Sana Biotechnology, Inc. Tandem fusogens and related lipid particles
AU2024301706A1 (en) 2023-07-21 2026-02-05 Crispr Therapeutics Ag Modulating expression of alas1 (5'-aminolevulinate synthase 1) gene
WO2025038881A1 (en) * 2023-08-16 2025-02-20 Beam Therapeutics Inc. Prime editing of single base mutations in sickle cell disease
WO2025049563A1 (en) * 2023-08-28 2025-03-06 University Of Florida Research Foundation, Inc. A programmable gene correction technology using cas-polymerase constructs
AU2024335327A1 (en) * 2023-09-01 2026-03-26 Renagade Therapeutics Management Inc. Gene editing systems, compositions, and methods for treatment of vexas syndrome
WO2025054202A1 (en) 2023-09-05 2025-03-13 Sana Biotechnology, Inc. Method of screening a sample comprising a transgene with a unique barcode
WO2025076306A1 (en) 2023-10-06 2025-04-10 University Of Massachusetts Prime editors having improved prime editing efficiency
WO2025096936A2 (en) 2023-11-03 2025-05-08 The Broad Institute, Inc. Use of prime editing in correcting mutations in cdkl5
WO2025111452A2 (en) * 2023-11-21 2025-05-30 Prime Medicine, Inc. CHEMICAL MODIFICATIONS IN PEgRNA and ngRNAs
KR20250075782A (ko) * 2023-11-21 2025-05-29 경상국립대학교산학협력단 교정 정밀도가 향상된 프라임 에디팅 시스템 및 이의 용도
CN117497092B (zh) * 2024-01-02 2024-05-14 微观纪元(合肥)量子科技有限公司 基于动态规划和量子退火的rna结构预测方法及系统
WO2025151814A1 (en) 2024-01-10 2025-07-17 The Broad Institute, Inc. Use of prime editing in correcting mutations in cftr
WO2025151838A1 (en) 2024-01-12 2025-07-17 Sana Biotechnology, Inc. Safety switches to control in vitro and in vivo proliferation of cell therapy products
EP4600357A1 (en) * 2024-02-12 2025-08-13 Technische Universität München Delivery system for gene editing tools
WO2025184529A1 (en) 2024-03-01 2025-09-04 Sana Biotechnology, Inc. Viral particles with fusogen display and related compositions and methods
WO2025188920A1 (en) 2024-03-06 2025-09-12 Mdx Management Llc Local application of agents inhibiting tyrosine kinase or shp-1 signaling
WO2025212519A1 (en) 2024-04-01 2025-10-09 Moonlight Bio, Inc. Dll3 binding proteins and uses thereof
US20250313863A1 (en) * 2024-04-09 2025-10-09 Trustees Of Boston University ENGINEERED CIRCULARIZED pegRNAs AND USES THEREOF
WO2025217616A1 (en) 2024-04-12 2025-10-16 The Broad Institute, Inc. Prime editing and base editing of the atp1a3 gene for the treatment of alternating hemiplegia of childhood
WO2025235828A2 (en) * 2024-05-08 2025-11-13 The General Hospital Corporation Engineered prime editors for treating genetic deafness
WO2025240795A1 (en) * 2024-05-15 2025-11-20 President And Fellows Of Harvard College End-modified grnas for improved base editing
WO2025250677A1 (en) * 2024-05-28 2025-12-04 The Trustees Of The University Of Pennsylvania Compositions and methods for correction of trex1 mutations
CN118581153A (zh) * 2024-08-05 2024-09-03 崖州湾国家实验室 Dna聚合酶介导的核苷酸序列编辑方法及组合物
WO2026069163A1 (en) 2024-09-25 2026-04-02 Crispr Therapeutics Ag Differentiation method for producing immature beta cells

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663290A (en) 1982-01-21 1987-05-05 Molecular Genetics, Inc. Production of reverse transcriptase
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US5079352A (en) 1986-08-22 1992-01-07 Cetus Corporation Purified thermostable enzyme
US5374553A (en) 1986-08-22 1994-12-20 Hoffmann-La Roche Inc. DNA encoding a thermostable nucleic acid polymerase enzyme from thermotoga maritima
US5244797B1 (en) 1988-01-13 1998-08-25 Life Technologies Inc Cloned genes encoding reverse transcriptase lacking rnase h activity
FR2632821B1 (fr) 1988-06-22 1990-11-16 Inst Kriobiologii Procede de conservation a basse temperature des embryons
US5270179A (en) 1989-08-10 1993-12-14 Life Technologies, Inc. Cloning and expression of T5 DNA polymerase reduced in 3'- to-5' exonuclease activity
US5047342A (en) 1989-08-10 1991-09-10 Life Technologies, Inc. Cloning and expression of T5 DNA polymerase
JP2709311B2 (ja) 1990-09-28 1998-02-04 エフ．ホフマン−ラ ロシュ アクチェンゲゼルシャフト 熱安定性ｄｎａポリメラーゼの５→３′のエキソヌクレアーゼ突然変異
AU8906091A (en) 1990-10-05 1992-04-28 Wayne M. Barnes Thermostable dna polymerase
US5496714A (en) 1992-12-09 1996-03-05 New England Biolabs, Inc. Modification of protein by use of a controllable interveining protein sequence
US5834247A (en) 1992-12-09 1998-11-10 New England Biolabs, Inc. Modified proteins comprising controllable intervening protein sequences or their elements methods of producing same and methods for purification of a target protein comprised by a modified protein
US5436149A (en) 1993-02-19 1995-07-25 Barnes; Wayne M. Thermostable DNA polymerase with enhanced thermostability and enhanced length and efficiency of primer extension
US5512462A (en) 1994-02-25 1996-04-30 Hoffmann-La Roche Inc. Methods and reagents for the polymerase chain reaction amplification of long DNA sequences
US5912155A (en) 1994-09-30 1999-06-15 Life Technologies, Inc. Cloned DNA polymerases from Thermotoga neapolitana
US5614365A (en) 1994-10-17 1997-03-25 President & Fellow Of Harvard College DNA polymerase having modified nucleotide binding site for DNA sequencing
US5773258A (en) 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
US6183998B1 (en) 1998-05-29 2001-02-06 Qiagen Gmbh Max-Volmer-Strasse 4 Method for reversible modification of thermostable enzymes
GB9920194D0 (en) 1999-08-27 1999-10-27 Advanced Biotech Ltd A heat-stable thermostable DNA polymerase for use in nucleic acid amplification
EP1235914A2 (en) 1999-11-24 2002-09-04 Joseph Rosenecker Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
US8178291B2 (en) 2005-02-18 2012-05-15 Monogram Biosciences, Inc. Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors
US9783791B2 (en) 2005-08-10 2017-10-10 Agilent Technologies, Inc. Mutant reverse transcriptase and methods of use
EP2139909A4 (en) * 2007-03-22 2010-04-07 Univ Yale Inc PREQ1-RIBOSWITCHES AND METHOD AND COMPOSITIONS FOR USE BY AND WITH PREQ1-RIBOSWITCHES
CN101668848B (zh) 2007-04-26 2014-10-22 雷蒙特亚特特拉维夫大学有限公司 来自口腔粘膜的多能自体干细胞和使用方法
WO2010028347A2 (en) 2008-09-05 2010-03-11 President & Fellows Of Harvard College Continuous directed evolution of proteins and nucleic acids
US10113156B2 (en) 2009-03-04 2018-10-30 Board Of Regents, The University Of Texas System Stabilized reverse transcriptase fusion proteins
US8889394B2 (en) 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
WO2011072246A2 (en) 2009-12-10 2011-06-16 Regents Of The University Of Minnesota Tal effector-mediated dna modification
WO2012054727A1 (en) 2010-10-22 2012-04-26 Bio-Rad Laboratories, Inc. Reverse transcriptase mixtures with improved storage stability
CA2825370A1 (en) 2010-12-22 2012-06-28 President And Fellows Of Harvard College Continuous directed evolution
WO2012125445A2 (en) 2011-03-11 2012-09-20 President And Fellows Of Harvard College Small molecule-dependent inteins and uses thereof
KR102096534B1 (ko) 2011-09-28 2020-04-03 에라 바이오테크, 에스.에이. 분할된 인테인 및 그의 이용
EP3431497B1 (en) 2012-06-27 2022-07-27 The Trustees of Princeton University Split inteins, conjugates and uses thereof
US9181535B2 (en) 2012-09-24 2015-11-10 The Chinese University Of Hong Kong Transcription activator-like effector nucleases (TALENs)
DK2904101T3 (da) 2012-10-03 2019-08-12 Agrivida Inc Intein-modificerede proteaser, fremstilling deraf og industrielle anvendelser
JO3470B1 (ar) 2012-10-08 2020-07-05 Merck Sharp & Dohme مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9228207B2 (en) * 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
WO2015134121A2 (en) 2014-01-20 2015-09-11 President And Fellows Of Harvard College Negative selection and stringency modulation in continuous evolution systems
CN107075491B (zh) 2014-10-28 2021-07-06 谷万达公司 用于稳定反式剪接的内含肽修饰的蛋白酶的方法和组合物
WO2016168631A1 (en) 2015-04-17 2016-10-20 President And Fellows Of Harvard College Vector-based mutagenesis system
ES2985812T3 (es) * 2016-09-09 2024-11-07 The Board Of Trustees Of The Leland Stanfordjunior Univ Edición genómica de precisión de alto rendimiento
US9580698B1 (en) 2016-09-23 2017-02-28 New England Biolabs, Inc. Mutant reverse transcriptase
US11560566B2 (en) * 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
US10011849B1 (en) * 2017-06-23 2018-07-03 Inscripta, Inc. Nucleic acid-guided nucleases
US11268092B2 (en) * 2018-01-12 2022-03-08 GenEdit, Inc. Structure-engineered guide RNA
KR20250133482A (ko) * 2018-05-11 2025-09-05 빔 테라퓨틱스, 인크. 프로그래밍가능한 염기 편집기 시스템을 이용하여 단일 뉴클레오티드 다형성을 편집하는 방법
WO2020191233A1 (en) * 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
IL297761A (en) * 2020-05-08 2022-12-01 Broad Inst Inc Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence

Similar Documents

Publication Publication Date Title
JP2023543803A5 (https=)
Woodson et al. Proteins that chaperone RNA regulation
JP2018509915A5 (https=)
JP2017532042A5 (https=)
JP2023513955A5 (https=)
JP2006526394A5 (https=)
ATE500344T1 (de) Einfach-primernukleinsäuren-erweiterungsverfahr n
JP2008295444A5 (https=)
JP2008532477A5 (https=)
JP2017527313A5 (https=)
JP2024531728A5 (https=)
JPH04503752A (ja) インビトロでのｄｎａの増幅、ゲノムクローニングおよびマッピングの、改良された方法
JP2024511163A5 (https=)
Glew et al. Expression studies on four members of the pMGA multigene family in Mycoplasma gallisepticum 56
WO2018152323A1 (en) Compositions and methods for template-free enzymatic nucleic acid synthesis
Reeder et al. The mechanism of transcription termination by RNA poiymerase I
JP7465507B2 (ja) Ｓｔａｐｌｅ核酸を利用したタンパク質翻訳反応の抑制法
WO2005116265A3 (en) Probe arrays for expression profiling of rat genes
KR101508219B1 (ko) 포도상구균의 테이코산에 대한 ｒｎａ 앱타머
JP6811843B2 (ja) 個々の細胞から対合ｍＲＮＡを捕捉及びシーケンスするためのボウタイ状バーコードの油乳化剤の大量合成
Greenblatt et al. Structure and mechanism in transcriptional antitermination by the bacteriophage λ N protein
US9695417B2 (en) Method for large-scale synthesis of long-chain nucleic acid molecule
JP2024534856A5 (https=)
AU2003243094B2 (en) Randomised DNA libraries and double-stranded RNA libraries, use and method of production thereof
Ringo Fundamental genetics